ICENI Seedcord Fund LLP invests £200k in

Wednesday 1st of October 2003 8:00

ICENI Seedcord Fund LLP invests £200k in
Immunoporation Ltd

06 October 2003, Immunoporation Ltd a spin out from the University of Essex has been created to commercially exploit its unique portfolio of technologies for moving DNA and other potentially therapeutic molecules efficiently into human cells for a diverse range of applications from Gene therapy to Cancer Research.

The technology has received peer review praise for its future potential with articles published in the scientific journal 'Nature' and a SMART feasibility award. One of its patented technologies has already been out licensed for development within the Plant and Microbial markets.

Tom Hole, MD at Immunoporation, said 'the company has an exciting opportunity to develop its products successfully into most of the Life Science markets where existing technologies have real limitations. The Funding from Iceni will provide an important platform to expand its operation into a commercial entity capable of penetrating these highly profitable markets.' 

Bill Huston, an Iceni Investment Executive member, explained 'the combined benefit of having significant technical advances linked to a short time to market, made Immunoporation an attractive investment to Iceni, this university spin-out represents our goal of supporting projects and companies capable of moving academic ideas and inventions into viable and successful businesses'.

Immunoporation has offices and laboratories based in Maidstone and Colchester, and has two core and unique patented Transfection technologies, Immunoporation and Aeroporation currently under development. It is envisaged that the company will exploit these technologies through its own branded product ranges, as well as exploring private label, licensing and other Joint Venturing agreements, to maximise the opportunities within each of the market sectors for Medical Research, Gene Therapy, Cell Engineering, Target and Drug Discovery, Plant and Fungal transformation. For more information regarding Immunoporation and its products, please contact Tom Hole, CEO, 01622 842297, info@immunoporation.com, www.immunoporation.com

The Iceni Seedcorn Fund LLP is a partnership between the University of East Anglia, the University of Essex, The John Innes Centre, the Sainsbury Laboratory, the Institute of Food Research and Plant Bioscience Limited. The £4m fund was established with an award under the DTI's University Challenge Fund (UCF) competition and with contributions from the partners and HSBC Bank. NW Brown Ventures Ltd, a company regulated by the FSA, is the appointed fund manager and member of the ICENI Investment Executive. For further information please contact Max Bautin, 01223 720227, www.icenifund.com 

Related Web-Links

Download PDF